20993 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
Antisense modulation of PTP1B expression
#302Compounds and methods for increasing neurogenesis
#303Treatment of gestational diabetes
#304Inhibition of PACAP signalling for the prevention and treatment of thrombocytopenia
#305Glp-1 and methods for treating diabetes
#306Absorption enhancers for drug administration
#307Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists
#308Use of neuropeptides for ligament healing
#309Modification of feeding behavior using PYY and GLP-1
#310Use of ingap for reversing diabetes
#311Polymer-based sustained release device
#312Method of treating the syndrome of coronary heart disease risk factors in humans
#313Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor
#314Transmucosal delivery of peptides and proteins
#315Compounds and methods for increasing neurogenesis
#316GLP-1 pharmaceutical compositions
#317Method for treating lung diseases associated with ventilation-perfusion mismatches
#318Pharmaceutical compositions comprising vip-related peptides for the treatment of sexual disorders
#319Methods and compositions for treating ocular disorders
#320Inotropic and diuretic effects of GLP-1 and GLP-1 agonists
#321Materials and methods for making improved micelle compositions
#322Medicinal compositions for nasal absorption
#323Compounds and methods for increasing neurogenesis